US Stock MarketDetailed Quotes
ELAB Elevai Labs
- 0.019
- +0.001+5.59%
Close Nov 8 16:00 ET
- 0.019
- 0.000-1.06%
Post 20:01 ET
933.21KMarket Cap-75P/E (TTM)
0.021High0.018Low438.79MVolume0.021Open0.018Pre Close8.94MTurnover1116.51%Turnover RatioLossP/E (Static)49.38MShares4.24452wk High0.36P/B742.77KFloat Cap0.01652wk Low--Dividend TTM39.30MShs Float4.244Historical High--Div YieldTTM13.97%Amplitude0.016Historical Low0.020Avg Price1Lot Size
About Elevai Labs Company
Elevai Labs, Inc. is a physician-dispensed skincare company, which engages in the research and development of skincare formulations. It is involved in the production and commercialization of topical skincare products that contain its proprietary stem cell-derived Elevai Exosomes. The company was founded by Hatem Abou-Sayed and Jordan R. Plews in 2020 and is headquartered in Newport Beach, CA.
Company Profile
SymbolELAB
Company NameElevai Labs
Listing DateNov 21, 2023
Issue Price4.00
Founded2020
CEOMr. Graydon Bensler
MarketNASDAQ
Employees18
Fiscal Year Ends12-31
Address120 Newport Center Drive,Suite 250
CityNewport Beach
ProvinceCalifornia
CountryUnited States of America
Zip Code92660
Phone1-866-794-4940
Websitehttp://elevaiskincare.com
Company Executives
-
Name
- Position
- Salary
-
Dr. Jordan R. Plews, Pd.D
- President and Director; Chief Executive Officer of Elevai Skincare Inc and Elevai Biosciences Inc
- 200.00K
-
Graydon Bensler
- Chief Executive Officer, Chief Financial Officer, Principle Accounting Officer and Director
- --
-
Braeden Lichti
- Non-Executive Chairman of the Board
- --
-
George Kovalyov
- Independent Director
- --
-
Juliana L. Daley
- Independent Director
- --
-
Jeffrey Owen Parry BA,MBA
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data